Life-Stress Interview for Women With Chronic Urogenital Pain Conditions

Sponsor
William Beaumont Hospitals (Other)
Overall Status
Completed
CT.gov ID
NCT02286115
Collaborator
Wayne State University (Other)
70
1
2
16
4.4

Study Details

Study Description

Brief Summary

The goal of this study is to test the efficacy, feasibility, and acceptability of providing an experiential assessment interview that targets health, and emotional and stressful experiences in a tertiary care setting specializing in women's urology.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Life-Stress Interview
N/A

Detailed Description

In this randomized, controlled trial, the investigators will compare an interview condition to a wait-list control condition. The investigators hypothesize that helping individuals identify the links between their stress, emotions, and physical symptoms will likely increase their awareness and endorsement of the link between stress and physical symptoms, including a willingness to engage in stress management techniques. It is also expected that helping raise an individual's awareness about their symptoms, followed by an experience and expression of unexpressed emotion is likely to influence their physical and psychological well-being.

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Life-Stress Interview for Women With Chronic Urogenital Pain Conditions
Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Jan 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Life-Stress Interview

The Life-Stress Interview is an experiential assessment technique

Behavioral: Life-Stress Interview
A life-stress interview which aims to help patients: a) disclose their stressful experiences and emotional conflicts, which might be contributing to their symptoms, b) learn about associations between their stress and physical symptoms; and c) learn about the potential value of experiencing and expressing their emotions related to these stressful situations

No Intervention: Wait-list Control

Wait-list Control

Outcome Measures

Primary Outcome Measures

  1. Symptom Interpretation Questionnaire (SIQ) [Change from baseline symptom attribution at 6-weeks]

  2. Brief Pain Inventory (BPI) [Change from baseline pain at 6-weeks]

Secondary Outcome Measures

  1. Patient Health Questionnaire-15 (PHQ-15) [Change from baseline in symptom severity at 6 weeks]

  2. Brief Symptom Inventory (BSI) [Change from baseline symptoms at 6-weeks]

  3. Satisfaction With Life Scale (SWLS) [Change from baseline life satisfaction at 6-weeks]

  4. Pelvic Floor Distress Inventory -20 (PFDI-20) [Change from baseline pelvic symptoms at 6-weeks]

  5. Global Assessment Response (GRA) [Change from baseline overall symptoms at 6-weeks]

  6. Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) [Change from baseline pain at 6-weeks]

  7. Emotional Approach Coping (EAC) [Change from baseline emotional approach coping at 6-weeks]

  8. Emotional Processing Scale-25 (EPS-25) [Change from baseline emotional processing at 6-weeks]

  9. Inventory of Interpersonal Problems-32 (IIP-32) [Change from baseline interpersonal problems at 6-weeks]

  10. Pain Catastrophizing Scale [Change from baseline pain catastrophizing at 6-weeks]

  11. Change Assessment Questionnaire [Change from baseline stage of change at 6-weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants must have a chronic urogenital pain condition
Exclusion Criteria:
  • non-English speaking

  • unable to read

  • psychosis

  • dementia

  • mental impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Women's Urology Center Royal Oak Michigan United States 48073

Sponsors and Collaborators

  • William Beaumont Hospitals
  • Wayne State University

Investigators

  • Principal Investigator: Jennifer Carty, M.A., Beaumont Health Systems and Wayne State University
  • Principal Investigator: Mark A Lumley, PhD, Wayne State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT02286115
Other Study ID Numbers:
  • HIC.2014-151
First Posted:
Nov 7, 2014
Last Update Posted:
Dec 14, 2016
Last Verified:
Dec 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by William Beaumont Hospitals
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 14, 2016